Back to Search
Start Over
Panel rejects omalizumab for 6- to 11-year-olds
- Source :
- Family Practice News. December 1, 2009, Vol. 39 Issue 21, p62, 1 p.
- Publication Year :
- 2009
-
Abstract
- SILVER SPRING, MD. -- The majority of a Food and Drug Administration advisory panel did not support expanding the approval of omalizumab as a treatment for moderate to severe persistent [...]
- Subjects :
- United States. Food and Drug Administration -- Laws, regulations and rules
Drug therapy
Reports
Dosage and administration
Laws, regulations and rules
Government regulation
Childhood asthma -- Drug therapy
Antiasthmatic agents -- Laws, regulations and rules -- Dosage and administration
Advisory boards -- Reports
Omalizumab -- Dosage and administration -- Laws, regulations and rules
Asthma in children -- Drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 03007073
- Volume :
- 39
- Issue :
- 21
- Database :
- Gale General OneFile
- Journal :
- Family Practice News
- Publication Type :
- Periodical
- Accession number :
- edsgcl.219900048